|
|
(members only)
|
URCC U3905 - "Yoga for Persistent Sleep Disturbance in Cancer Survivors"
Treatment Plan (Supplied Drug: N/A)
Study Week 1 (Baseline)
Randomize to: Arm 1 (Standard Care) or Arm 2 (Standard Care + Yoga Intervention)
Assess sleep, fatigue, QOL, mood, symptoms, sleep med usage, & activity at end of week on Friday or Saturday
Start 7 days of actigraphy at beginning of wk (Sunday at noon)
Start daily diaries at beginning of wk on Sunday
Study Weeks 2-5 (Intervention)
Arm 1: Standard care + monitoring. Pts will not receive yoga. They will be offered yoga at no charge following conclusion of study.
Arm 2: Standard care + 4-wk yoga intervention (2x/wk for 75 mins each time)
Study Week 6 (Post)
Assess sleep, fatigue, QOL, mood, symptoms, sleep med usage, & activity and complete feedback at end of week on Friday or Saturday
Start 7 days of actigraphy at beginning of wk (Sunday at noon)
End daily diaries on last day of post-tx actigraphy asmt (Sunday)
Eligibility
Confirmed dx of any type of cancer. Can have >1 primary. No mets cancer.
Undergone some type or combination of standard tx (surgery, chemo, RT) for cancer.
Completed all forms of standard therapy for cancer (surgery, chemo, RT) between 2 & 24 mos pre-enrollment. May be taking hormones or monoclonal antibodies.
Persistent sleep disturbance (response >3 on 11 point scale: "0"=no sleep disturbance and "10"=worst possible sleep disturbance).
Able to read English.
Age >21.
No regular (>1 days/wk) participation in yoga classes or maintained regular personal practice of yoga in any form w/i 3 mos pre-study enrollment. Participants cannot plan to start yoga on their own during time they are enrolled in the study.
No confirmed dx of sleep apnea.
Not receiving any form of cancer tx, except for hormonal therapy.
PRESTUDY REQUIREMENTS:
Demographics, sleep hx, etc.
Clinical record information
Chemo flow sheet &/or RT tx summary (copy from chart)
Lab tests (if w/i last 3 mos - copy from chart)
Signed informed consent.